Page last updated: 2024-08-26

syringaresinol and Acute Lung Injury

syringaresinol has been researched along with Acute Lung Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Cui, L; Hao, J; Li, C; Li, D; Li, J; Wang, X; Yang, L; Zhang, L; Zhang, Q; Zhang, S; Zhuo, Y1
Cui, L; He, S; Hu, D; Wang, X; Yang, L; Zhang, L; Zhang, S; Zhao, J; Zhuo, Y1

Other Studies

2 other study(ies) available for syringaresinol and Acute Lung Injury

ArticleYear
Syringaresinol Resisted Sepsis-Induced Acute Lung Injury by Suppressing Pyroptosis Via the Oestrogen Receptor-β Signalling Pathway.
    Inflammation, 2022, Volume: 45, Issue:2

    Topics: Acute Lung Injury; Animals; Furans; Lignans; Mice; Mice, Inbred C57BL; Pyroptosis; Receptors, Estrogen; Sepsis

2022
Syringaresinol alleviates IgG immune complex induced acute lung injury via activating PPARγ and suppressing pyroptosis.
    International immunopharmacology, 2023, Volume: 124, Issue:Pt B

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antigen-Antibody Complex; Caspase 1; Immunoglobulin G; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; PPAR gamma; Pyroptosis

2023